Table 2.
HIV Characteristics of Study Population (N =50)
| Variable | Results | ||
|---|---|---|---|
| n (%) | M (SD) | Median (range) | |
| Mode of HIV transmission | |||
| Perinatal | 40 (80.0) | ||
| Sexual | 10 (20.0) | ||
| CDC stage | |||
| Stage 1 (Asymptomatic) | 6 (12.0) | ||
| Stage 2 | 20 (40.0) | ||
| Stage 3 (AIDS) | 24 (48.0) | ||
| AIDS diagnosis | |||
| Yes | 24 (48.0) | ||
| No | 26 (52.0) | ||
| Log10 HIV viral load (copies/ml) | 1.18 (1.84) | 0 (0–5.42) | |
| Log10 HIV viral load dichotomized | |||
| < 400 copies/ml | 37 (74.0) | ||
| > 400 copies/ml | 13 (26.0) | ||
| CD4+T lymphocyte count (cells/mm3) | 562.88 (310.94) | 552.5 (3 – 1584.0) | |
| CD4+T-lymphocyte percentage | 26.98 (9.81) | 28.0 (1 – 42.0) | |
| Adherence dichotomized | |||
| 100% reported adherence | 35 (70.0) | ||
| < 100 % reported adherence | 15 (30.0) | ||
| 3-day self-reported adherence estimates | 86.0 (26.92) | 100.0 (0–100) | |
NOTE: M = mean; SD = standard deviation